Taurine hypomodification underlies mitochondrial tRNATrp-related genetic diseases

Jia-Li Lu,Yichen Dai,Kunqian Ji,Gui-Xin Peng,Hong Li,Chuanzhu Yan,Bin Shen,Xiao-Long Zhou
DOI: https://doi.org/10.1093/nar/gkae854
IF: 14.9
2024-10-10
Nucleic Acids Research
Abstract:E scherichia c oli MnmE and MnmG form a complex ( Ec MnmEG), generating transfer RNA (tRNA) 5-carboxymethylaminomethyluridine (cmnm 5 U) modification. Both cmnm 5 U and equivalent 5-taurinomethyluridine (τm 5 U, catalyzed by homologous GTPBP3 and MTO1) are found at U34 in several human mitochondrial tRNAs (hmtRNAs). Certain mitochondrial DNA (mtDNA) mutations, including m.3243A > G in tRNA Leu (UUR) and m.8344A > G in tRNA Lys , cause genetic diseases, partially due to τm 5 U hypomodification. However, whether other mtDNA variants in different tRNAs cause a defect in τm 5 U biogenesis remains unknown. Here, we purified naturally assembled Ec MnmEG from E. coli . Notably, Ec MnmEG was able to incorporate both cmnm 5 U and τm 5 U into hmtRNA Trp (encoded by MT-TW ), providing a valuable basis for directly monitoring the effects of mtDNA mutations on U34 modification. In vitro , several clinical hmtRNA Trp pathogenic mutations caused U34 hypomodification. A patient harboring an m.5541C > T mutation exhibited hmtRNA Trp τm 5 U hypomodification. Moreover, using mtDNA base editing, we constructed two cell lines carrying m.5532G > A or m.5545C > T mutations, both of which exhibited hmtRNA Trp τm 5 U hypomodification. Taurine supplementation improved mitochondrial translation in patient cells. Our findings describe the third hmtRNA species with mutation-related τm 5 U-hypomodification and provide new insights into the pathogenesis and intervention strategy for hmtRNA Trp -related genetic diseases.
biochemistry & molecular biology
What problem does this paper attempt to address?